Skip to main content

Short Bowel Syndrome clinical trials at UCSF
2 in progress, 2 open to new patients

  • A Prospective, Multi-center Registry for Patients With Short Bowel Syndrome

    open to all eligible people

    This is a global prospective, observational, multi-center registry to evaluate the long-term safety profile for patients with short bowel syndrome (SBS) who are treated with teduglutide in a routine clinical setting. The registry will also evaluate the long-term clinical outcomes in patients with SBS. SBS patients treated and not treated with teduglutide will be enrolled.

    San Francisco, California and other locations

  • Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome (SBS) Who Completed TED-C14-006

    open to all eligible people

    This study will follow subjects who completed the TED-C14-006 study. The purpose of this study is to evaluate the long-term safety and efficacy of teduglutide in pediatric subjects with Short Bowel Syndrome (SBS). This study will also offer teduglutide treatment to eligible subjects, regardless of treatment received in TED-C14-006.

    San Francisco, California and other locations